Literature DB >> 35917005

The protective effect of Palmatine on depressive like behavior by modulating microglia polarization in LPS-induced mice.

Lei Wang1, Min Li2, Cuiping Zhu3, Aiping Qin1, Jinchun Wang4, Xianni Wei5.   

Abstract

The purpose of the present study was to evaluate the protective effect of Palmatine on LPS-induced depressive like behavior and explore its potential mechanism. The mice were intragastrically treated with Fluoxetine or Palmatine once daily for 1 week. After the last drug administration, the mice were intraperitoneally challenged with LPS and suffered for Sucrose preference test, Tail suspension test, Forced swimming test and Open field test. The pro-inflammatory biomarkers were measured by ELISA, qPCR, WB and immunofluorescence. As a result, the administration of Palmatine effectively lessened depressive-like behavior. Palmatine could decrease the levels of pro-inflammatory cytokines TNF-α, IL-6, the expressions of CD68, iNOS mRNA, as well as increase the levels of anti-inflammatory cytokines IL-4, IL-10, the expressions of CD206, Arg1 mRNA, Ym1 mRNA both in LPS-induced mice and in LPS-induced BV2 cells. The beneficial effect of Palmatine might be attributed to the suppression of M1 microglia polarization and the promotion of M2 microglia polarization via PDE4B/KLF4 signaling. The similar results were observed in CUMS-induced depressive mice. The transfection with PDE4B SiRNA or KLF4 SiRNA indicated that PDE4B and KLF4 were both involved in the Palmatine-mediated microglia polarization. Molecular docking indicated that Palmatine could interact with PDE4B. In conclusion, this research demonstrated that Palmatine attenuated depressive like behavior by modulating microglia polarization via PDE4B/KLF4 signaling.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Depressive like behavior; LPS; Microglia polarization; PDE4B; Palmatine

Mesh:

Substances:

Year:  2022        PMID: 35917005     DOI: 10.1007/s11064-022-03672-3

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   4.414


  40 in total

1.  The role of CCR5 in the protective effect of Esculin on lipopolysaccharide-induced depressive symptom in mice.

Authors:  Tong Chen; Menglin Zheng; Yixuan Li; Shengnan Liu; Ling He
Journal:  J Affect Disord       Date:  2020-09-01       Impact factor: 4.839

2.  Zinc inhibited LPS-induced inflammatory responses by upregulating A20 expression in microglia BV2 cells.

Authors:  Li Hongxia; Tang Yuxiao; Shen Zhilei; Sun Yan; Qu Yicui; Shen Jiamin; Xu Xin; Yang Jianxin; Mo Fengfeng; Shen Hui
Journal:  J Affect Disord       Date:  2019-02-12       Impact factor: 4.839

3.  Involvement of exchange protein directly activated by cAMP and tumor progression locus 2 in IL-1β production in microglial cells following activation of β-adrenergic receptors.

Authors:  Hidetoshi Tozaki-Saitoh; Izumi Sasaki; Tomohiro Yamashita; Masako Hosoi; Takahiro A Kato; Makoto Tsuda
Journal:  J Pharmacol Sci       Date:  2020-03-21       Impact factor: 3.337

4.  Iridoids from Gardeniae fructus ameliorates depression by enhancing synaptic plasticity via AMPA receptor-mTOR signaling.

Authors:  Baomei Xia; Xiaoyan Huang; Guangda Sun; Weiwei Tao
Journal:  J Ethnopharmacol       Date:  2020-12-08       Impact factor: 4.360

5.  Overexpression of phosphodiesterase-4 subtypes involved in surgery-induced neuroinflammation and cognitive dysfunction in mice.

Authors:  Wei Wang; Xiao-Ying Zhang; Ze-Guo Feng; Dong-Xin Wang; Hao Zhang; Bo Sui; Yong-Yi Zhang; Wei-Xing Zhao; Qiang Fu; Zhi-Peng Xu; Wei-Dong Mi
Journal:  Brain Res Bull       Date:  2017-02-21       Impact factor: 4.077

6.  Etazolate abrogates the lipopolysaccharide (LPS)-induced downregulation of the cAMP/pCREB/BDNF signaling, neuroinflammatory response and depressive-like behavior in mice.

Authors:  J Guo; P Lin; X Zhao; J Zhang; X Wei; Q Wang; C Wang
Journal:  Neuroscience       Date:  2014-01-13       Impact factor: 3.590

7.  Endotoxin produces a depressive-like episode in rats.

Authors:  R Yirmiya
Journal:  Brain Res       Date:  1996-03-04       Impact factor: 3.252

8.  Rolipram optimizes therapeutic effect of bevacizumab by enhancing proapoptotic, antiproliferative signals in a glioblastoma heterotopic model.

Authors:  Sara Ramezani; Nasim Vousooghi; Fatemeh Ramezani Kapourchali; Shahrokh Yousefzadeh-Chabok; Zoheir Reihanian; Ali Mohammad Alizadeh; Saeed Khodayari; Hamid Khodayari
Journal:  Life Sci       Date:  2019-10-31       Impact factor: 5.037

9.  Geniposide protects depression through BTK/JAK2/STAT1 signaling pathway in lipopolysaccharide-induced depressive mice.

Authors:  Menglin Zheng; Ke Li; Tong Chen; Shengnan Liu; Ling He
Journal:  Brain Res Bull       Date:  2021-02-06       Impact factor: 4.077

10.  A Mechanistic Rationale for PDE-4 Inhibitors to Treat Residual Cognitive Deficits in Acquired Brain Injury.

Authors:  Rudy Schreiber; Romain Hollands; Arjan Blokland
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.